A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections

N Wu, J Zhang, Y Shen, X Zhang, J Zhou, Y Wu, E Li… - Molecular Therapy, 2024 - cell.com
As the world continues to confront severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), respiratory syncytial virus (RSV) is also causing severe respiratory illness in millions …
被引用次数：4 相关文章

A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections

N Wu, J Zhang, Y Shen, X Zhang… - … therapy: the journal …, 2024 - pubmed.ncbi.nlm.nih.gov
As the world continues to confront severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), respiratory syncytial virus (RSV) is also causing severe respiratory illness in millions …

A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections.

N Wu, J Zhang, Y Shen, X Zhang, J Zhou… - … Therapy: the Journal …, 2024 - europepmc.org
As the world continues to confront severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), respiratory syncytial virus (RSV) is also causing severe respiratory illness in millions …

A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections

N Wu, J Zhang, Y Shen, X Zhang, J Zhou, Y Wu, E Li… - Molecular Therapy, 2024 - cell.com
As the world continues to confront severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), respiratory syncytial virus (RSV) is also causing severe respiratory illness in millions …

A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections

N Wu, J Zhang, Y Shen, X Zhang, J Zhou, Y Wu, E Li… - Molecular Therapy, 2024 - Elsevier
As the world continues to confront severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), respiratory syncytial virus (RSV) is also causing severe respiratory illness in millions …